A Phase 3 Study Of Lenalidomide Versus Placebo In Rbc Transfusion-Dependent (Td) Patients With Lower-Risk Mds Without Del(5Q) Unresponsive Or Refractory To Erythropoiesis-Stimulating Agents (Esas)

AuthID
P-00P-BV1
22
Author(s)
Santini, V
·
Giagounidis, A
·
Groepper, S
·
Jonasova, A
·
Vey, N
·
Mufti, GJ
·
Buckstein, R
·
Mittelman, M
·
Platzbecker, U
·
[+2]·
del Canizo, C
·
Gattermann, N
·
Ozawa, K
·
Risueno, A
·
MacBeth, KJ
·
Zhong, J
·
Seguy, F
·
Hoenekopp, A
·
Beach, CL
·
Fenaux, P
Tipo de Documento
Abstract
Year published
2015
Publicado
in LEUKEMIA RESEARCH, ISSN: 0145-2126
Volume: 39, Páginas: S60-S61 (2)
Conference
13Th International Symposium on Myelodysplastic Syndromes (Mds), Date: APR 29-MAY 02, 2015, Location: Washington, DC
Indexing
Publication Identifiers
Wos: WOS:000373183500118
Source Identifiers
ISSN: 0145-2126
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Santini, V;   2 Almeida, A;   3 Giagounidis, A;
4 Groepper, S;   5 Jonasova, A;   6 Vey, N;
7 Mufti, GJ;   8 Buckstein, R;   9 Mittelman, M;
10 Platzbecker, U;   11 Shpilberg, O;   12 Ram, R;
13 del Canizo, C;   14 Gattermann, N;   15 Ozawa, K;
16 Risueno, A;   17 MacBeth, KJ;   18 Zhong, J;
19 Seguy, F;   20 Hoenekopp, A;   21 Beach, CL;
22 Fenaux, P;